115 related articles for article (PubMed ID: 11441307)
1. [Possible value of positive PSA levels in malignant and nonmalignant breast diseases].
Schuff-Werner P; Zingler C
Onkologie; 2001 Feb; 24 Suppl 1():11-7. PubMed ID: 11441307
[TBL] [Abstract][Full Text] [Related]
2. [Prostate specific antigen in women].
Michał K; Stanisław R
Ginekol Pol; 2010 Sep; 81(9):704-7. PubMed ID: 20973208
[TBL] [Abstract][Full Text] [Related]
3. [Limitations on the interpretation of prostate-specific antigen serum levels].
Sciarra A; Casale P; Di Nicola S; Di Chiro C; Colella D; Di Silverio F
Minerva Urol Nefrol; 1999 Jun; 51(2):105-12. PubMed ID: 10429421
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast.
Black MH; Diamandis EP
Breast Cancer Res Treat; 2000 Jan; 59(1):1-14. PubMed ID: 10752675
[TBL] [Abstract][Full Text] [Related]
5. Serum total and free prostate-specific antigen for breast cancer diagnosis in women.
Black MH; Giai M; Ponzone R; Sismondi P; Yu H; Diamandis EP
Clin Cancer Res; 2000 Feb; 6(2):467-73. PubMed ID: 10690525
[TBL] [Abstract][Full Text] [Related]
6. Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women.
Romppanen J; Keskikuru R; Kataja V; Eskelinen M; Kosma VM; Savolainen K; Uusitupa M; Mononen I
Br J Cancer; 1999 Mar; 79(9-10):1583-7. PubMed ID: 10188910
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen kinetics in localized and advanced prostate cancer.
Fitzpatrick JM; Banu E; Oudard S
BJU Int; 2009 Mar; 103(5):578-87. PubMed ID: 19210674
[TBL] [Abstract][Full Text] [Related]
8. Nadir prostate-specific antigen best predicts the progression to androgen-independent prostate cancer.
Morote J; Trilla E; Esquena S; Abascal JM; Reventos J
Int J Cancer; 2004 Mar; 108(6):877-81. PubMed ID: 14712491
[TBL] [Abstract][Full Text] [Related]
9. [Significance of the PSA-concentration for the detection of prostate cancer].
Stachon A
Pathologe; 2005 Nov; 26(6):469-72. PubMed ID: 16195861
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of prostate-specific antigen as a surrogate marker for response of hormone-refractory prostate cancer to suramin therapy.
Sridhara R; Eisenberger MA; Sinibaldi VJ; Reyno LM; Egorin MJ
J Clin Oncol; 1995 Dec; 13(12):2944-53. PubMed ID: 8523059
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen screening: pro.
Loeb S; Catalona WJ
Curr Opin Urol; 2010 May; 20(3):185-8. PubMed ID: 20224413
[TBL] [Abstract][Full Text] [Related]
12. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. I. PSA, PSA density, and predicted PSA].
Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Allona Almagro A; Gomez dos Santos V
Arch Esp Urol; 1997 May; 50(4):333-8. PubMed ID: 9313041
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of serum markers for prostate cancer.
Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
[TBL] [Abstract][Full Text] [Related]
14. [Prostate-specific antigen (PSA) in women].
Kamenov Z; Todorova M; Khristov V
Vutr Boles; 2001; 33(1):40-7. PubMed ID: 11785088
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen in breast cyst fluid: possible role of prostate-specific antigen in hormone-dependent breast cancer.
Lai LC; Erbas H; Lennard TW; Peaston RT
Int J Cancer; 1996 Jun; 66(6):743-6. PubMed ID: 8647643
[TBL] [Abstract][Full Text] [Related]
16. [New challenges and earlier approved methods in the laboratory diagnosis of prostate cancer].
Kovács GL
Magy Onkol; 2014 Dec; 58(4):301-9. PubMed ID: 25517448
[TBL] [Abstract][Full Text] [Related]
17. ["Prostatic" kallikreins, sex hormones and insulin-like growth factors: complex of male and female regulatory elements in health and carcinogenesis].
Zezerov EG; Severin ES
Vestn Ross Akad Med Nauk; 1999; (3):49-56. PubMed ID: 10222833
[TBL] [Abstract][Full Text] [Related]
18. The lady with raised prostate specific antigen: do we need to worry?
Das S; Paul R; De U; Mukhopadhyay M
Asian Pac J Cancer Prev; 2011; 12(8):2051-3. PubMed ID: 22292649
[TBL] [Abstract][Full Text] [Related]
19. Prostate-Specific Antigen as a Marker of Hyperandrogenism in Women and Its Implications for Antidoping.
Musrap N; Diamandis EP
Clin Chem; 2016 Aug; 62(8):1066-74. PubMed ID: 27259815
[TBL] [Abstract][Full Text] [Related]
20. [Serum markers for early detection and staging of prostate cancer. Status report on current and future markers].
Haese A; Graefen M; Palisaar J; Huland E; Huland H
Urologe A; 2003 Sep; 42(9):1172-87. PubMed ID: 14504750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
